11/18/2024
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
5:57 PM | Aligos Therapeutics (Subject)
Vivo Capital Fund VIII, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:19 PM | Aligos Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
3:34 PM | Aligos Therapeutics (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G/A | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Aligos Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
4:20 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2024
4:14 PM | Aligos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
|
11/06/2024
3:24 PM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
3:16 PM | Achneck Hardean (Reporting)
Aligos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:15 PM | Achneck Hardean (Reporting)
Aligos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
3:22 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:23 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:23 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:06 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:14 PM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
4:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
4:27 PM | Aligos Therapeutics (Filer)
| Form PRE 14A | |
03/12/2024
3:51 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
3:15 PM | Aligos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
4:44 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:41 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:28 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:30 PM | Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:31 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:33 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:34 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:35 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:23 PM | Aligos Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/08/2024
4:44 PM | Aligos Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
01/30/2024
6:04 AM | Aligos Therapeutics (Subject)
| Form SC TO-I | |
01/25/2024
5:06 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
5:12 AM | Aligos Therapeutics (Subject)
| Form SC TO-C | |
11/28/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 424B3 | |
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad) One tiny company...
Could quickly become "the next SpaceX."
It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00.
Get urgent details inside this free report... The Next SpaceX Pre-IPO |
11/27/2023
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
Free ALGS Stock Alerts